Zhanna A. Startseva

Zhanna A. Startseva

Auto-generated profile, based on publicly available information

Zhanna A. Startseva

Tomsk National Research Medical Center of the Russian Academy of Sciences

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in AIP Conference Proceedings
Verified
Conference Paper
Open access
VVV. V. Velikaya
V. V. Velikaya
LML. I. Musabaeva
L. I. Musabaeva
VLV. A. Lisin
V. A. Lisin
ZSZh. A. Startseva
Zh. A. Startseva
The study included 135 breast cancer patients (70 patients with locally recurrent breast cancer and 65 patients with locally advanced breast cancer with unfavorable prognostic factors) who received the neutron therapy alone or in combination with the photon therapy. The neutron therapy was shown to be effective in multimodality treatment of patients with locally advanced and locally recurrent breast cancer. The 8-year survival rate in patients without repeated breast cancer recurrence was 87.6 ± 8.7% after the neutron and neutron-photon therapy and 54.3 ± 9.2% after the electron beam therapy.

1 January 2016 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
VSV. Yu. Skoropad
V. Yu. Skoropad
SASergey G. Afanasyev
Sergey G. Afanasyev
GSGamayunov Sergey
Gamayunov Sergey
TAT. A. Agababyan
T. A. Agababyan
MVM. Yu. Volkov
M. Yu. Volkov
ZYZ. K. Yakushina
Z. K. Yakushina
ПЛАНИРУЕМОЕ МНОГОЦЕНТРОВОЕ РАНДОМИЗИРОВАННОЕ КЛИНИЧЕСКОЕ ИССЛЕДОВАНИЕ II ФАЗЫ: НЕОАДЪЮВАНТНАЯ ХИМИОЛУЧЕВАЯ ТЕРАПИЯ С ПОСЛЕДУЮЩЕЙ ГАСТРЭКТОМИЕЙ D2 И АДЪЮВАНТНОЙ ХИМИОТЕРАПИЕЙ У БОЛЬНЫХ МЕСТНОРАСПРОСТРАНЕННЫМ РАКОМ ЖЕЛУДКА

Verified
Journal Article
Open access
PDF file
NYNatalia v Yunusova
Natalia v Yunusova
DSDmitry Andreevich Svarovsky
Dmitry Andreevich Svarovsky
AKArtem I. Konovalov
Artem I. Konovalov
DKDmitry Kostromitskiy
Dmitry Kostromitskiy
ZSZhanna A. Startseva
Zhanna A. Startseva
STSvetlana Tamkovich
Svetlana Tamkovich
The majority of colorectal cancer patients (CRCPs) develop tumors on the background of “metabolically healthy obesity” or metabolic syndrome. The aim of the work was to study the levels of matrix metalloproteinases (MMPs) and heat shock proteins (HSPs) on the surface of blood plasma CD9-positive and FABP4-positive small extracellular vesicles (sEVs) from CRCPs depending on metabolic status and tumor angiogenesis, as well as to evaluate the sEVs markers as predictors of the effectiveness of thermoradiotherapy. In CRCPs, compared with patients with colorectal polyps (CPPs), the proportion of triple positive EVs and EVs with the MMP9+MMP2-TIMP1+ phenotype increased significantly among FABP4-positive EVs (adipocyte-derived EVs), which in general may indicate the overexpression of MMP9 and TIMP1 by adipocytes or adipose tissue macrophages in CRCPs. The results obtained have prospects for use as markers to clarify cancer risk in CPPs. One can assume that for CRCPs with metabolic syndrome or metabolically healthy obesity, it is the FABP4+MMP9+MMP2-TIMP1- population of circulating sEVs that is the most optimal biomarker reflecting tumor angiogenesis. Determining this population in the blood will be useful in monitoring patients after treatment for the early detection of tumor progression. CD9+MMP9+MMP2-TIMP1- and MMP9+MMP2-TIMP1+ subpopulations of circulating sEVs are the most promising predictors of the efficacy of thermoradiation therapy because their levels at baseline differ significantly in CRCPs with different tumor responses.

1 January 2016 in Siberian journal of oncology
Verified
Journal Article
Open access
PDF file
LML. I. Musabaeva
L. I. Musabaeva
ECE. L. Choinzonov
E. L. Choinzonov
OGO. V. Gribova
O. V. Gribova
ZSZh. A. Startseva
Zh. A. Startseva
VVV. V. Velikaya
V. V. Velikaya
VLV. A. Lisin
V. A. Lisin
Представлены результаты комплексного и комбинированного лечения с применением быстрых нейтронов у больных с резистентными формами злокачественных новообразований различных локализаций. Оценка эффективности нейтронной терапии на циклотроне У-120 проведена по критериям резорбции опухоли, продолжительности безрецидивного периода и пятилетней выживаемости. При применении нейтронной и нейтронно-фотонной терапии как при комбинированном лечении, так в виде самостоятельного метода лучевого лечения показана ее большая эффективность по сравнению с фотонной терапией. Разработана комплексная программа по предупреждению и лечению острых лучевых повреждений, возникающих при нейтронной и нейтронно-фотонной терапии.

29 October 2021 in Tumors of female reproductive system
Verified
Journal Article
Open access
PDF file
Alena ChernyshovaAlena Chernyshova
Alena Chernyshova
LKL. A. Kolomiets
L. A. Kolomiets
YTYu. M. Trushchuk
Yu. M. Trushchuk
OSO. V. Shpileva
O. V. Shpileva
Evgeny DenisovEvgeny Denisov
Evgeny Denisov
ЮТЮ. М. Трущук
Ю. М. Трущук
Currently, approaches to the choice of treatment tactics for cervical cancer have changed significantly. According to the recommendations of ESGO (2018), RUSSCO (2020), the use of a combination of surgical treatment and radiation therapy significantly increases the incidence of complications. Therefore, when planning the treatment of patients with IB1–IIA1, a combination of surgical treatment and radiation therapy should be avoided. The article presents an analysis of modern approaches to the treatment of initial, locally advanced and advanced cervical cancer. Modern approaches to organ-preserving treatment are considered, including the view from the point of view of expanding the indications for trachelectomy as part of combined treatment. The question of the expediency of using hyperthermia and indications for this type of treatment in combination with radiation therapy is considered. The author presents his own view of the problem as a whole and possible ways to solve this problem.

12 August 2024 in Almanac of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NYNatalia v Yunusova
Natalia v Yunusova
DSDmitry Andreevich Svarovsky
Dmitry Andreevich Svarovsky
AKArtem I. Konovalov
Artem I. Konovalov
DKDmitry Kostromitskiy
Dmitry Kostromitskiy
IKIrina V. Kondakova
Irina V. Kondakova
КНКостромицкий Дмитрий Николаевич
Костромицкий Дмитрий Николаевич
Background: Overweight and especially obesity are associated with the risk of the development and progression of colorectal cancer. It can be assumed that there are multifaceted interactions between the tumor and adipose tissue during anti-tumor treatment. Cancer cells secrete exosomes, extracellular vesicles affecting the microenvironment of the tumor and promoting its progression or regression. The presence of transcription/translation/folding factors (heat shock proteins (HSPs), matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in exosomes secreted by irradiated cells and cells exposed to hyperthermia, indicates the cell adaptation to the thermal and radiation stress. Aim: To analyze the MMPs, TIMP1, and HSPs on CD9-positive (CD9+) exosomes, as well as on exosomes of adipocytic origin (FABP4+) in rectal cancer patients with overweight/obesity under thermoradiochemotherapy (TRCT) and their association with the immediate treatment efficacy. Methods: Since 2021, 20 patients (of those 8 men; median age 59.0 [52.0; 63.0] years, median body mass index 29.6 [28.5; 33.1] kg/m2) with morphologically verified rectal cancer (T3-4N0M0 and T3-4N1M0, differentiation grade G1–G3) have been participating in the study. They were treated with TRCT: external gamma therapy (2 Gy, 1 fraction/day, 5 days/week, total focal dose 54 Gy), chemotherapy with capecitabine (825 mg/m2 twice daily) combined with local hyperthermia (42–44 °C, 60 min, 3 times/week, 10 sessions). The TRCT efficacy was assessed by RECIST 1.1 and ESGAR criteria. Blood samples for exosomes were taken from the patients at baseline (point 1), in the middle of the treatment course (point 2), at 6 to 10 weeks after the end of TRCT (point 3), and at 6 months after point 1 (point 4). Small extracellular vesicles were isolated from plasma by ultrafiltration with double ultracentrifugation. The isolated exosomes were characterized by transmission electronic microscopy, flow cytometry and nanoparticle trajectory analysis (NTA). Results: TRCT resulted in complete tumor regression in 13/20 of the rectal cancer patients and partial regression or stabilization in 7/20. Four subpopulations of CD9+ and FABP4+ exosomes associated with the TRCT efficacy were identified (CD9+MMP2+, СD9+MMP2+9+TIMP1+, СD9+MMP2+9+TIMP1-, and FABP4+MMP2+9-TIMP1+). Compared to the CD9+ exosomes, the adipocytic vesicles had higher MMP2 expression (p = 0.026); however, the adipocyte vesicles subpopulation were virtually free of vesicles with combined MMP2 and MMP9 gelatinase expression. The HSPs expression by circulating exosomes at various TRCT steps was associated neither with direct treatment efficacy nor with the vesicle type. Conclusion: The expression of MMPs and TIMP1 on CD9+ and FABP4+ exosomes is associated with TRCT efficacy. In the future, vesicular markers could be used to build prognostic models, to identify patient groups with an unfavorable prognosis, and to personalize treatment and follow-up.